Guidelines for the management of chronic kidney disease

Adeera Levin, Brenda Hemmelgarn, Bruce Culleton, Sheldon Tobe, Philip McFarlane, Marcel Ruzicka, Kevin Burns, Braden Manns, Colin White, Francoise Madore, Louise Moist, Scott Klarenbach, Brendan Barrett, Robert Foley, Kailash Jindal, Peter Senior, Neesh Pannu, Sabin Shurraw, Ayub Akbari, Adam CohnMartina Reslerova, Vinay Deved, David Mendelssohn, Gihad Nesrallah, Joanne Kappel, Marcello Tonelli

Research output: Contribution to journalReview articlepeer-review

237 Scopus citations
Original languageEnglish (US)
Pages (from-to)1154-1162
Number of pages9
JournalCMAJ
Volume179
Issue number11
DOIs
StatePublished - Nov 18 2008

Bibliographical note

Funding Information:
Philip McFarlane has been a consultant to or an advisory board member of Ortho Biotech, Amgen, Sanofi-Aventis, Bristol-Myers Squibb, Biovail, Pfizer, Novartis, AstraZeneca, Fresenius, Boehringer Ingelheim, Roche and Schering-Plough. He has received honoraria for presentations from Ortho-Biotech, Amgen, Sanofi-Aventis, Bristol-Myers Squibb, Biovail, Novartis, Abbott and Merck. Philip McFarlane has participated in or received research grant funding from Sanofi-Aventis, GlaxoSmithKline, Biovail, Boehringer Ingelheim, AstraZeneca, Ortho Biotech and Amgen.

Funding Information:
Kevin Burns has received educational grants from Hoffman LaRoche, Bristol-Myers Squibb, Sanofi-Aventis and Pfizer Canada.

Cite this